金融界消息 截至2025年8月13日收盘，健麾信息（605186）报收于24.25元，上涨2.06%，换手率 3.31%，成交量4.50万手，成交金额1.08亿元。 资金流向方面，今日主力资金净流入1283.28万元，占比成交额11.86%。其中，超大单净流入416.96万 元、占成交额3.85%，大单净流入866.32万元、占成交额8.0%，中单净流出流入1.95万元、占成交额 0.02%，小单净流出1285.23万元、占成交额11.88%。 健麾信息最新一期业绩显示，截至2025一季报，公司营业总收入7706.22万元、同比增长116.27%，归属 净利润342.61万元，同比减少34.65%，扣非净利润329.38万元，同比减少30.93%，流动比率2.393、速动 比率2.160、资产负债率21.15%。 天眼查商业履历信息显示，上海健麾信息技术股份有限公司，成立于2014年，位于上海市，是一家以从 事专用设备制造业为主的企业。企业注册资本13600万人民币，实缴资本10200万人民币。公司法定代表 人为戴建伟。 通过天眼查大数据分析，上海健麾信息技术股份有限公司共对外投资了29家企业，参与招投标项目 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Jianhui Information, which closed at 23.76 yuan with a PE ratio of 105.24, marking a new low in 118 days, and a total market capitalization of 3.231 billion yuan [1][2] - The average PE ratio for the medical services industry is 48.17, with a median of 63.54, positioning Jianhui Information at the 37th rank within the industry [1][2] - As of March 31, 2025, Jianhui Information has 16,423 shareholders, an increase of 939 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Jianhui Information focuses on providing intelligent management products and services for the medical services and pharmaceutical distribution sectors, with key products including smart pharmacy projects and intelligent logistics solutions [1] - The latest quarterly report for Q1 2025 shows Jianhui Information achieved a revenue of 77.0622 million yuan, a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, reflecting a year-on-year decrease of 34.65%, with a gross margin of 37.17% [1]

健麾信息最新一期业绩显示，截至2025一季报，公司营业总收入7706.22万元、同比增长116.27%，归属 净利润342.61万元，同比减少34.65%，扣非净利润329.38万元，同比减少30.93%，流动比率2.393、速动 比率2.160、资产负债率21.15%。 天眼查商业履历信息显示，上海健麾信息技术股份有限公司，成立于2014年，位于上海市，是一家以从 事专用设备制造业为主的企业。企业注册资本13600万人民币，实缴资本10200万人民币。公司法定代表 人为戴建伟。 通过天眼查大数据分析，上海健麾信息技术股份有限公司共对外投资了29家企业，参与招投标项目35 次，知识产权方面有商标信息25条，专利信息56条，此外企业还拥有行政许可20个。 来源：金融界 金融界消息 截至2025年8月12日收盘，健麾信息（605186）报收于23.76元，上涨1.24%，换手率 4.66%，成交量6.34万手，成交金额1.52亿元。 资金流向方面，今日主力资金净流入2536.86万元，占比成交额16.7%。其中，超大单净流入458.48万 元、占成交额3.02%，大单净流入2078.38万元、占成交额13.69% ...

Company Overview - The company, Shanghai Jianhui Information Technology Co., Ltd., focuses on providing intelligent management solutions for the pharmaceutical and medical service industries [1] - Main products include smart pharmacy projects, intelligent central preparation centers, intelligent drug consumables management, logistics and mobile robotics projects, maintenance services, and other business revenues [1] Financial Performance - For Q1 2025, the company reported revenue of 77.06 million yuan, a year-on-year increase of 116.27% [1] - Net profit for the same period was 3.43 million yuan, showing a year-on-year decrease of 34.65% [1] - The gross profit margin was reported at 37.17% [1] Market Position - The company's stock closed at 22.66 yuan, with a PE ratio of 100.37, marking a new low in 11 days [1] - The total market capitalization is 3.082 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical services sector is 47.79, with a median of 59.03, placing the company at 38th in the industry ranking [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 16,423, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Jianhui Information, which operates in the medical services sector, showing a high PE ratio compared to industry averages [1][2] - As of July 30, Jianhui Information's stock closed at 22.08 yuan, down 1.43%, with a rolling PE ratio of 97.80 times and a total market capitalization of 3.003 billion yuan [1] - The average PE ratio for the medical services industry is 48.15 times, with a median of 61.34 times, placing Jianhui Information at the 38th position within the industry [1][2] Group 2 - As of March 31, 2025, Jianhui Information had 16,423 shareholders, an increase of 939 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - The company's main business focuses on providing intelligent management products and services for the pharmaceutical and medical service industries, including smart pharmacy projects and logistics solutions [1] - In the latest quarterly report for Q1 2025, Jianhui Information reported revenue of 77.0622 million yuan, a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, reflecting a year-on-year decrease of 34.65%, with a gross margin of 37.17% [1]

Core Viewpoint - As of July 25, 2025, Jianhui Information (605186) closed at 22.48 yuan, down 1.19% from the previous week, with a current market capitalization of 3.057 billion yuan [1] Company Announcement Summary - Jianhui Information transferred its holding of 15 million shares of a private equity fund to Huang Zhihong at a transfer price of 0 yuan. After the transfer, the company still holds 15 million shares of the Hongsheng Houde Fund, which has a total scale of 570.71 million yuan and a duration of 7 years, focusing on venture investments in the healthcare industry [1] - The company is a general partner in the fund, with a subscribed capital of 30 million yuan and a paid-in capital of 15 million yuan, representing a subscription ratio of 5.2566%. The transaction was approved by the company's chairman and does not require board or shareholder approval, not constituting a related party transaction or a major asset restructuring [1] - The transfer agreement stipulates that the transfer price is 0 yuan, and the transferee commits to timely and fully completing the capital contribution and cooperating with the relevant change registration procedures. This transaction is beneficial for the company to optimize its investment structure and layout, aligning with its overall strategic planning, and will not have a significant impact on the company's financial status and operational activities [1]

Core Viewpoint - Shanghai Jianhui Information Technology Co., Ltd. has announced the transfer of 15 million shares of the Shanghai Hongsheng Houde Private Equity Fund to Huang Zhihong for a transfer price of RMB 0, aiming to optimize its investment structure and focus on its core business [2][3][15]. Group 1: Transaction Overview - The company participated in the establishment of the Hongsheng Houde private equity fund in 2023, with a total fund size of RMB 570.71 million and a duration of 7 years, targeting investments in the healthcare industry [3]. - The company is a general partner in the fund, with a subscribed capital of RMB 30 million, of which RMB 15 million has been paid [3]. - The transfer agreement allows the company to transfer its unpaid capital contribution of RMB 15 million to Huang Zhihong, with the transfer price set at RMB 0 [3][8]. Group 2: Fund and Transfer Details - The Hongsheng Houde fund is a limited partnership established on March 15, 2023, with a total capital of RMB 570.71 million [6]. - The fund's main activities include private equity investment, investment management, and asset management, subject to registration with the Asset Management Association of China [7]. - The transfer does not involve any debt transfer, and the ownership of the fund shares is clear, with no encumbrances or legal disputes affecting the transfer [7][9]. Group 3: Impact on the Company - The transfer of the fund shares is part of the company's strategy to streamline external investments and focus on its main business, aligning with its overall strategic planning [15]. - The transaction is not expected to have a significant impact on the company's financial status or operational activities, nor does it harm the interests of shareholders, especially minority investors [15].

证券代码：605186 证券简称：健麾信息 公告编号：2025-023 根据《上海健麾信息技术股份有限公司章程》、《上海证券交易所股票上市 规则》等相关规定，本次交易在公司董事长的审批范围内，无需提交董事会、股 东大会审议。本次交易事项不构成关联交易，也不构成《上市公司重大资产重组 1 上海健麾信息技术股份有限公司 关于部分转让私募投资基金份额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 上海健麾信息技术股份有限公司（以下简称"公司"）将其持有并尚未完成实 缴的 1,500.00 万份上海弘盛厚德私募投资基金合伙企业（有限合伙）（以下简称 "弘盛厚德"）基金份额转让给黄志鸿，转让价格为人民币 0 元。上述财产份额 转让完成后，公司持有弘盛厚德基金份额 1,500 万份。 一、交易概述 公司于 2023 年参与投资设立私募投资基金弘盛厚德，该基金规模为人民币 5.7071 亿元，存续期限 7 年，投资目标为从事医疗健康行业的创业投资活动。 其中，公司为一般有限合伙人，认缴出资人民币 3,000.00 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Jianhui Information, which operates in the medical services sector, showing a high PE ratio compared to industry averages [1][2] - As of July 18, Jianhui Information's closing stock price was 22.75 yuan, with a PE ratio of 100.77, significantly higher than the industry average of 44.90 [1][2] - The company's total market capitalization is 3.094 billion yuan, ranking it 39th in the medical services industry based on PE ratio [1][2] Group 2 - Jianhui Information reported a revenue of 77.0622 million yuan for Q1 2025, reflecting a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, down 34.65% year-on-year [1] - The company's gross profit margin stands at 37.17%, indicating its profitability in the current market environment [1] - As of March 31, 2025, Jianhui Information had 16,423 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]

Core Viewpoint - Shanghai Jianhui Information Technology Co., Ltd. anticipates a significant decline in net profit for the first half of 2025 compared to the same period last year, with projections indicating a decrease of 72.92% to 83.08% [1][2]. Performance Forecast - The company expects a net profit attributable to shareholders of the parent company to be between 5 million to 8 million yuan, a decrease of 21.54 million to 24.54 million yuan year-on-year [1]. - The projected net profit after deducting non-recurring gains and losses is estimated to be between 4.8 million to 7.8 million yuan, reflecting a year-on-year decrease of 1.46 million to 1.76 million yuan [2]. Previous Year’s Performance - For the first half of 2024, the company reported a total profit of 34.56 million yuan and a net profit attributable to shareholders of the parent company of 29.54 million yuan [2]. - The earnings per share for the same period were 0.22 yuan [2]. Reasons for Performance Change - The company has experienced stable revenue growth due to the recovery of core business operations and steady expansion in overseas markets, with expected revenue between 150 million to 160 million yuan [2][3]. - The company is actively investing in emerging business areas such as intelligent distribution centers and logistics, which are contributing to an increasing revenue share [2]. - The company has made significant progress in key overseas markets, including Saudi Arabia and Russia, leading to a gradual increase in overseas business revenue [2]. Future Outlook - The emerging business segments are still in the cultivation phase, with profit margins lower than traditional businesses [3]. - The company is increasing its R&D investments to advance new product development and technology upgrades, which are expected to lay a foundation for future growth [3]. - Continuous optimization of the business structure and improvement in operational efficiency are anticipated to enhance the company's profitability in the future [3].